Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol

Muhammad Hasan1, Dharmesh Patel1, Natalie Ellis2

  • 1Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.

Insights

Cholesterol significantly impacts the structure of the Neu receptor

Area of Science:

  • Biophysics
  • Molecular Biology
  • Biochemistry

Background:

  • The ErbB receptor family is crucial in cancer, particularly breast cancer.
  • A specific mutation (V664E) in the Neu receptor's transmembrane domain triggers oncogenic transformation.
  • The influence of cholesterol on Neu receptor structure remains largely unknown.

Purpose of the Study:

  • To investigate how cholesterol content affects the structure of the Neu receptor transmembrane domain.
  • To understand the interplay between cholesterol, receptor interactions, and bilayer mechanics.
  • To propose a model for cholesterol's role in Neu receptor activation.

Main Methods:

  • High-resolution magic angle spinning solid-state NMR was used.
  • 13C-13C coupling of selectively labeled residues in the Neu transmembrane domain was measured.
  • Experiments were conducted in lipid bilayers with varying cholesterol concentrations.

Main Results:

  • Inter-helical coupling was observed, supporting known dimerization motifs (A661-XXX-G665 and I659-XXX-V663).
  • Changes in cholesterol concentration altered transmembrane domain interactions and bilayer properties.
  • Evidence suggests the Neu transmembrane domain recognizes and binds cholesterol.

Conclusions:

  • Cholesterol plays a significant role in modulating the structure and interactions of the Neu transmembrane domain.
  • A novel model is proposed where cholesterol binding influences receptor activity.
  • These findings have implications for understanding cancer development and potential therapeutic strategies.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.2K
Membrane Fluidity01:26

Membrane Fluidity

Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
14.6K
Membrane Fluidity01:23

Membrane Fluidity

Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
173.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
469
Membrane Domains01:18

Membrane Domains

The membrane domains concentrate specific lipids and proteins at one place within the membrane, which helps in cell signaling, adhesion, and other critical cellular processes. These domains can differ in size, composition, function, and lifespan.
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
7.1K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.1K